Accelerating the Development of New Pet Medicines\n\nThe Animal and Plant Quarantine Agency (APQA) has announced it will increase its support for developing new veterinary drugs (medicines specifically designed to treat or prevent illness in animals). For two years in a row, the agency has been helping private companies create better medicines for pets.\n\nThis initiative aims to reduce reliance on expensive imported drugs and create safer, more effective options using domestic technology. By supporting local research, pet owners can expect better access to affordable healthcare for their furry family members.\n\n### Why Support for New Drug Development Matters\n\nCreating a new drug is a complex process that requires high costs and advanced technology. The APQA acts as a guide, providing professional consulting to help companies navigate the difficult testing and registration phases.\n\n> \"Our goal is to ensure that animals in our country benefit from safe and effective medicines developed with our own technology,\" the agency emphasized during their announcement.\n\n---\n\n### Key Benefits of the Program\n\n- Expert Consulting: Helping companies understand and meet strict safety standards for new drugs.\n- Technology Matching: Connecting private firms with advanced research from universities and labs.\n- Faster Approval: Streamlining the review process so that safe medicines can reach the market more quickly.\n\nThese efforts are expected to make the domestic animal drug industry more competitive on the global stage. Ultimately, this means pet owners will have more reliable choices when their pets get sick.
